港股異動 | 美東汽車漲超9% 機構看高目標價至34港元
格隆匯1月9日丨美東汽車(1268.HK)近期表現活躍,現大幅拉昇漲超9%,報17.28港元,暫成交9115萬港元,總市值220億港元。麥格理最新報吿稱,首予美東汽車“跑贏大市”評級,目標價34港元。該行認為,美東在汽車經銷行業擁有獨特的模式,可以最大限度地提高營運效率以提高盈利能力、擴大現金流並進一步擴大業務規模,相信其2022-24財年每股盈利複合年增長率將優於2019-22財年。該行指出,公司2022-24財年淨利潤複合年增長率為37%,高於同業中升控股及永達汽車各26%及30%,因此美東汽車的較高估值屬合理。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.